Search research articles
Contact Us
Filters
Showing results (71-80 of 168) with videos related to
Page
of 17
Sort By:
Journal of Cardiovascular Pharmacology
|
December 25, 2002
ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channels
Françoise Goirand, Marc Bardou, Pascal Guerard, et al.
Vascular Pharmacology
|
June 14, 2006
Dissociation between vascular oxidative stress and cardiovascular function in Wistar Kyoto and spontaneously hypertensive rats
Pierre Sicard, Alexandra Oudot, Jean-Claude Guilland, et al.
Trends in Pharmacological Sciences
|
April 22, 2015
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette, Charles Guenancia, Aurélie Gudjoncik, et al.
Fundamental & Clinical Pharmacology
|
March 30, 2007
A peroxynitrite decomposition catalyst: FeTPPS confers cardioprotection during reperfusion after cardioplegic arrest in a working isolated rat heart model
Benjamin Lauzier, Pierre Sicard, Olivier Bouchot, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 15, 2006
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin
Zo Rakotoniaina, Pascal Guerard, Frederic Lirussi, et al.
European Journal of Pharmacology
|
September 16, 2006
Tubulin ligands suggest a microtubule-NADPH oxidase relationship in postischemic cardiomyocytes
Lisa Devillard, David Vandroux, Cindy Tissier, et al.
International Journal of Molecular Sciences
|
April 15, 2020
Anti-Aging Effects of GDF11 on Skin
Luc Rochette, Loubna Mazini, Alexandre Meloux, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 11, 2008
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat
Zo Rakotoniaina, Pascal Guerard, Frédéric Lirussi, et al.
Molecular Nutrition & Food Research
|
June 27, 2024
Short-Term Postnatal Overfeeding Induces Long-Lasting Cardiometabolic Syndrome in Mature and Old Mice Associated with Increased Sensitivity to Myocardial Infarction
Eve Rigal, Marie Josse, Camille Greco, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 10, 2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS
Pascal Guerard, Zo Rakotoniaina, Françoise Goirand, et al.
Page
of 17
Search research articles
Search
Showing results (71-80 of 168) with videos related to
Sort By:
Page
of 17
Journal of Cardiovascular Pharmacology
|
December 25, 2002
ETA, mixed ETA/ETB receptor antagonists, and protein kinase C inhibitor prevent acute hypoxic pulmonary vasoconstriction: influence of potassium channels
Françoise Goirand, Marc Bardou, Pascal Guerard, et al.
Vascular Pharmacology
|
June 14, 2006
Dissociation between vascular oxidative stress and cardiovascular function in Wistar Kyoto and spontaneously hypertensive rats
Pierre Sicard, Alexandra Oudot, Jean-Claude Guilland, et al.
Trends in Pharmacological Sciences
|
April 22, 2015
Anthracyclines/trastuzumab: new aspects of cardiotoxicity and molecular mechanisms
Luc Rochette, Charles Guenancia, Aurélie Gudjoncik, et al.
Fundamental & Clinical Pharmacology
|
March 30, 2007
A peroxynitrite decomposition catalyst: FeTPPS confers cardioprotection during reperfusion after cardioplegic arrest in a working isolated rat heart model
Benjamin Lauzier, Pierre Sicard, Olivier Bouchot, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
November 15, 2006
The protective effect of HMG-CoA reductase inhibitors against monocrotaline-induced pulmonary hypertension in the rat might not be a class effect: comparison of pravastatin and atorvastatin
Zo Rakotoniaina, Pascal Guerard, Frederic Lirussi, et al.
European Journal of Pharmacology
|
September 16, 2006
Tubulin ligands suggest a microtubule-NADPH oxidase relationship in postischemic cardiomyocytes
Lisa Devillard, David Vandroux, Cindy Tissier, et al.
International Journal of Molecular Sciences
|
April 15, 2020
Anti-Aging Effects of GDF11 on Skin
Luc Rochette, Loubna Mazini, Alexandre Meloux, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
June 11, 2008
Celecoxib but not the combination of celecoxib+atorvastatin prevents the development of monocrotaline-induced pulmonary hypertension in the rat
Zo Rakotoniaina, Pascal Guerard, Frédéric Lirussi, et al.
Molecular Nutrition & Food Research
|
June 27, 2024
Short-Term Postnatal Overfeeding Induces Long-Lasting Cardiometabolic Syndrome in Mature and Old Mice Associated with Increased Sensitivity to Myocardial Infarction
Eve Rigal, Marie Josse, Camille Greco, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology
|
August 10, 2006
The HMG-CoA reductase inhibitor, pravastatin, prevents the development of monocrotaline-induced pulmonary hypertension in the rat through reduction of endothelial cell apoptosis and overexpression of eNOS
Pascal Guerard, Zo Rakotoniaina, Françoise Goirand, et al.
Page
of 17